225 related articles for article (PubMed ID: 24492276)
1. The emerging roles of microvesicles in liver diseases.
Lemoinne S; Thabut D; Housset C; Moreau R; Valla D; Boulanger CM; Rautou PE
Nat Rev Gastroenterol Hepatol; 2014 Jun; 11(6):350-61. PubMed ID: 24492276
[TBL] [Abstract][Full Text] [Related]
2. Angiogenesis in chronic liver disease and its complications.
Coulon S; Heindryckx F; Geerts A; Van Steenkiste C; Colle I; Van Vlierberghe H
Liver Int; 2011 Feb; 31(2):146-62. PubMed ID: 21073649
[TBL] [Abstract][Full Text] [Related]
3. Intrahepatic angiogenesis and sinusoidal remodeling in chronic liver disease: new targets for the treatment of portal hypertension?
Thabut D; Shah V
J Hepatol; 2010 Nov; 53(5):976-80. PubMed ID: 20800926
[TBL] [Abstract][Full Text] [Related]
4. Peripheral blood microvesicles are potential biomarkers for hepatocellular carcinoma.
Wang W; Li H; Zhou Y; Jie S
Cancer Biomark; 2013; 13(5):351-7. PubMed ID: 24440975
[TBL] [Abstract][Full Text] [Related]
5. Disruption of negative feedback loop between vasohibin-1 and vascular endothelial growth factor decreases portal pressure, angiogenesis, and fibrosis in cirrhotic rats.
Coch L; Mejias M; Berzigotti A; Garcia-Pras E; Gallego J; Bosch J; Mendez R; Fernandez M
Hepatology; 2014 Aug; 60(2):633-47. PubMed ID: 24390792
[TBL] [Abstract][Full Text] [Related]
6. Angiogenesis in liver disease.
Fernández M; Semela D; Bruix J; Colle I; Pinzani M; Bosch J
J Hepatol; 2009 Mar; 50(3):604-20. PubMed ID: 19157625
[TBL] [Abstract][Full Text] [Related]
7. Differential role of circulating endothelial progenitor cells in cirrhotic patients with or without hepatocellular carcinoma.
Sieghart W; Fellner S; Reiberger T; Ulbrich G; Ferlitsch A; Wacheck V; Peck-Radosavljevic M
Dig Liver Dis; 2009 Dec; 41(12):902-6. PubMed ID: 19501032
[TBL] [Abstract][Full Text] [Related]
8. WNT/beta-catenin signaling in liver health and disease.
Thompson MD; Monga SP
Hepatology; 2007 May; 45(5):1298-305. PubMed ID: 17464972
[TBL] [Abstract][Full Text] [Related]
9. Human liver stem cell-derived microvesicles inhibit hepatoma growth in SCID mice by delivering antitumor microRNAs.
Fonsato V; Collino F; Herrera MB; Cavallari C; Deregibus MC; Cisterna B; Bruno S; Romagnoli R; Salizzoni M; Tetta C; Camussi G
Stem Cells; 2012 Sep; 30(9):1985-98. PubMed ID: 22736596
[TBL] [Abstract][Full Text] [Related]
10. Hepatic venous pressure gradient and outcomes in cirrhosis.
Ripoll C
J Clin Gastroenterol; 2007; 41 Suppl 3():S330-5. PubMed ID: 17975485
[TBL] [Abstract][Full Text] [Related]
11. Autophagy and microRNA dysregulation in liver diseases.
Kim KM; Kim SG
Arch Pharm Res; 2014; 37(9):1097-116. PubMed ID: 25015129
[TBL] [Abstract][Full Text] [Related]
12. Liver cirrhosis.
Pinzani M; Rosselli M; Zuckermann M
Best Pract Res Clin Gastroenterol; 2011 Apr; 25(2):281-90. PubMed ID: 21497745
[TBL] [Abstract][Full Text] [Related]
13. Pathogenic roles of microvesicles in diabetic retinopathy.
Zhang W; Chen S; Liu ML
Acta Pharmacol Sin; 2018 Jan; 39(1):1-11. PubMed ID: 28713160
[TBL] [Abstract][Full Text] [Related]
14. Increased angiogenesis and permeability in the mesenteric microvasculature of rats with cirrhosis and portal hypertension: an in vivo study.
Geerts AM; De Vriese AS; Vanheule E; Van Vlierberghe H; Mortier S; Cheung KJ; Demetter P; Lameire N; De Vos M; Colle I
Liver Int; 2006 Sep; 26(7):889-98. PubMed ID: 16911473
[TBL] [Abstract][Full Text] [Related]
15. Etiology and pathophysiology of portal hypertension.
Reichen J
Z Gastroenterol; 1988 Sep; 26 Suppl 2():3-7. PubMed ID: 3055716
[TBL] [Abstract][Full Text] [Related]
16. Role of Kupffer cells in the pathogenesis of liver disease.
Kolios G; Valatas V; Kouroumalis E
World J Gastroenterol; 2006 Dec; 12(46):7413-20. PubMed ID: 17167827
[TBL] [Abstract][Full Text] [Related]
17. Assessing portal hypertension in liver diseases.
Berzigotti A; Seijo S; Reverter E; Bosch J
Expert Rev Gastroenterol Hepatol; 2013 Feb; 7(2):141-55. PubMed ID: 23363263
[TBL] [Abstract][Full Text] [Related]
18. The effects of sorafenib on the portal hypertensive syndrome in patients with liver cirrhosis and hepatocellular carcinoma--a pilot study.
Pinter M; Sieghart W; Reiberger T; Rohr-Udilova N; Ferlitsch A; Peck-Radosavljevic M
Aliment Pharmacol Ther; 2012 Jan; 35(1):83-91. PubMed ID: 22032637
[TBL] [Abstract][Full Text] [Related]
19. Systemic haemodynamics in cirrhosis and portal hypertension with focus on vasoactive substances and prognosis.
Møller S
Dan Med Bull; 1998 Feb; 45(1):1-14. PubMed ID: 9504263
[No Abstract] [Full Text] [Related]
20. Update on new aspects of the renin-angiotensin system in liver disease: clinical implications and new therapeutic options.
Grace JA; Herath CB; Mak KY; Burrell LM; Angus PW
Clin Sci (Lond); 2012 Aug; 123(4):225-39. PubMed ID: 22548407
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
